Global Active Pharmaceutical Ingredients Market Share Is Expected To Grow At A CAGR Of 4.7% By 2030

23-Mar-2023 | Facts and Factors

According to Facts and Factors, the global active pharmaceutical ingredients market size was worth around USD 191.3 billion in 2022 and is predicted to grow to around USD 306.2 billion by 2030 with a compound annual growth rate (CAGR) of roughly 4.7% between 2023 and 2030.

The global industry refers to the activities related to the production and distribution of active substances that are crucial ingredients of pharmaceutical drugs and play an important role in the healthcare sector. Any medicinal drug capable of providing therapeutic relief to patients had active pharmaceutical ingredients (APIs) as a crucial component. APIs are of two types. They can either be created in laboratories using synthetic processes or they may be derived from plants and animals. They have applications in a wide range of medical drugs including over-the-counter medicines, prescription drugs, and generic medications.

Browse the full “Active Pharmaceutical Ingredients Market Size, Share, Growth Analysis Report By Type (Generic Active Pharmaceutical Ingredients and Innovative Active Pharmaceutical Ingredients), By Molecule (Large and Small), By Type of Manufacturer (Merchant and Capital), By Indications (Saxagliptin, Enoxaparin Sodium, Tamoxifen, Acetaminophen, Artemisinin, Ibuprofen Losartan Potassium, Naproxen, Sodium Chloride, Rufinamide, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2023 – 2030" report at https://www.fnfresearch.com/active-pharmaceutical-ingredient-market

The industry is heavily regulated since it concerns the physical and mental safety of the population and hence the ingredients must comply with regulatory measures and meet required safety standards before they are launched in the commercial market. It includes manufacturing and sales of a variety of products like biologics, small molecules, and peptides.

The global active pharmaceutical ingredients market is projected to grow owing to the growing demand for generic medicines. Factors like affordability, government initiatives, and patent expirations are leading to the growth in consumption and subsequent requirement for generic medicines which may work in the favor of the industry. Moreover, the rising number of geriatric populations that require intense medical care due to age-related conditions is also significantly driving the demand for medicinal drugs in the pharmaceutical and healthcare sector.

In addition to this, the surging production of cost-efficient generic medicines is leading to more people getting access to quality medical care. Furthermore, the healthcare sector has become equipped with advanced systems like augmented and virtual reality devices that allow them to provide enhanced patient care. Furthermore, the healthcare sector has become equipped with advanced systems like augmented and virtual reality devices that allow them to provide enhanced patient care which means that the demand for APIs is expected to continue growing.

However, the global industry also deals with several limitations and growth restrictions. One of the major restraints observed in the market is regards with the disruptions in the supply chain of raw materials and final goods. Several socio-economic factors determine international trade relations and the growing political tension between the western and the eastern region could impact the smooth supply of the products.

In addition to this, several challenges in terms of regulatory compliance along with rising competition also pose threat to the market. Furthermore, the production process of APIs includes the use of hazardous chemicals that generate significant waste which can be a cause of worry for the industry players. 

Growing demand for personalized medicines may provide growth opportunities while concerns over intellectual property rights could challenge market growth.

Segmental Overview:

The global active pharmaceutical ingredients market is segmented based on type, molecule, type of manufacturer, indications, and region.

Based on type, the global market segments are generic active pharmaceutical ingredients and innovative active pharmaceutical ingredients

Based on molecule, the global market divisions are large and small.

• The industry witnessed the highest growth in the small molecule segment in 2022 as compared to large molecules
• The complexities involved with the use of small molecules are relatively simpler than large molecule drugs
• Small molecule drugs can be easily manufactured or synthesized making them highly cost-effective
• Furthermore, they have a wider range of applications and can be consumed through injection, topically, or orally
• Small molecule drugs generally weigh less than 900 Dalton

Based on type of manufacturer, the global market segments are merchant and capital.

Based on indications, the global market is divided into saxagliptin, enoxaparin sodium, tamoxifen, acetaminophen, artemisinin, ibuprofen, losartan potassium, naproxen, sodium chloride, rufinamide, and others.

• All of the indications are important to market growth and it is difficult to determine which one is the most significant since each indication has specific role to play
• For instance, acetaminophen is used as a fever reducer and pain reliever that can be bought over-the-counter
• Tamoxifen is a selective estrogen receptor modulator (SERM) and is used to reduce the risk of developing breast cancer or treating the condition
• Enoxaparin sodium is used to prevent blood clots
• In a trial conducted by the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention, tamoxifen was concluded to have reduced the risk of invasive breast cancer by approximately 49%

Regional Overview:

Asia-Pacific is projected to register the highest growth in the global active pharmaceuticals ingredients market with India and China leading the regional growth. Asia-Pacific is home to more than 4.5 billion people which accounts for more than 50% of the world population. The rising prevalence of medical cases along with increasing investments in the already established pharmaceutical industry are major reasons for high growth.

Furthermore, the countries have favorable regulatory policies encouraging the development of new APIs and the use of existing ones for the production of generic medicines due to the growing demand for affordable healthcare. Europe and North America may benefit due to the presence of important players and increasing investments in research & development.

Report Scope

Competitive Landscape:

The global active pharmaceutical ingredients market is led by players like F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim, Sanofi, Mylan N.V., Pfizer Inc., Bristol-Myers Squibb, Novartis International AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Cambrex Corporation, Dr. Reddy's Laboratories, AbbVie Inc., Cipla Limited, BASF SE, GlaxoSmithKline plc, Merch & Co, Lonza Group, and Daiichi Sankyo Company, Limited.

Recent Developments:

• In February 2020, Sanofi, a French multinational pharmaceutical company, announced its intention to create a new dedicated leading company that will solely focus on the development of new APIs
• In July 2022, De Dietrich Process Systems, NovAliX, Bruker, and Alysophil joined forces to help in bringing a new approach to API production. The collaboration is expected to create assistance for contract manufacturing organizations (CMO) and pharma companies with location-independent API manufacturing solutions

The global active pharmaceutical ingredients market is segmented as follows:

By Type 

• Generic Active Pharmaceutical Ingredients
• Innovative Active Pharmaceutical Ingredients

By Molecule 

• Large
• Small

By Type of Manufacturer

• Capital

By Indications 

• Saxagliptin
• Enoxaparin Sodium
• Tamoxifen
• Acetaminophen
• Artemisinin
• Ibuprofen Losartan Potassium
• Naproxen
• Sodium Chloride
• Rufinamide
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com